Bilateral emphysematous pyelonephritis and emphysematous cystitis: a rare case report

Irfan Šabotić; Ahmo  Habibović; Irfan  Ćorović; Selma  Habibović

doi:10.2298/VSP240306026S

Irfan Šabotić University of Niš, Faculty of Medicine, Niš, Serbia; General Hospital of Novi Pazar, †Department of Urology Novi Pazar, Serbia
Ahmo Habibović General Hospital of Novi Pazar, Department of Radiology, Novi Pazar, Serbia
Irfan Ćorović General Hospital of Novi Pazar, Department of Internal Medicine, Novi Pazar, Serbia
Selma Habibović General Hospital of Novi Pazar, Institute of Public Health Novi Pazar, Department of Microbiology, Novi Pazar, Serbia

DOI: https://doi.org/10.2298/VSP240306026S

Ključne reči: pijelonefritis; cistitis; emfizem; dijabetes melitus; lečenje; ishod.

Sažetak

Uvod. Emfizematozni pijelonefritis (EP) je retka i teška infekcija bubrega koja dovodi do stvaranja gasova u bubrežnom parenhimu, sabirnom sistemu ili perirenalnom tkivu. Emfizematozni cistitis (EC) je retko i potencijalno fatalno stanje, koje karakteriše nakupljanje gasa u zidu i lumenu mokraćne bešike. Prikazan je slučaj EP sa EC kod osobe obolele od dijabetesa melitusa (DM). Prikaz bolesnika. Bolesnica stara 38 godina, sa loše regulisanim DM, hospitalizovana je na Odeljenju urologije u Opštoj bolnici Novi Pazar, Srbija, sa tegobama u vidu malaksalosti, povišene telesne temperature, bola u slabinskim regijama i donjem delu stomaka. Nakon kliničkog pregleda, laboratorijskih analiza i radiološke dijagnostike postavljena je dijagnoza obostranog EP sa EC. Sve vreme tokom hospitalizacije bolesnica je bila hemodinamski stabilna, sa očuvanom diurezom. Urinokultura i hemokultura bile su negativne. Bolesnica je lečena intravenskim rastvorima i antibioticima (metronidazol, vankomicin i meropenem). Nije bilo potrebe za drugim invazivnim oblikom lečenja, jer je konzervativna terapija bila uspešna. Zaključak. Blagovremenim uspostavljanjem dijagnoze i brzim uključivanjem antibiotske terapije omogućuje se izbegavanje invazivnog oblika lečenja kod bolesnika sa EP i EC. Primenjena konzervativna terapija imala je povoljan ishod kod prikazane bolesnice.

Reference

Boakes E, Batura D. Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy? Int Urol Nephrol 2017; 49(12): 2127–36.

Mnif MF, Kamoun M, Kacem FH, Bouaziz Z, Charf N, Mnif F, et al. Complicated urinary tract infections associated with diabetes mellitus: pathogenesis, diagnosis and management. Indian J Endocrinol Metab 2013; 17(3): 442–5.

Lu YC, Hong JH, Chiang BJ, Pong YH, Hsueh PR, Huang CY, et al. Recommended initial antimicrobial therapy for emphysematous pyelonephritis: 51 cases and 14-year-experience of a tertiary referral center. Medicine (Baltimore) 2016; 95(21): e3573.

Kelly H, MacCallum WG. Pneumaturia. JAMA 1898; 31(8): 375−81.

Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 2000; 160(6): 797−805.

Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology 1997; 49(3): 343−6.

Ćelić D, Božić D, Petrović K, Živojinov S, Djurdjević-Mirković T, Popović M. Emphysematous pyelonephritis – case report and review of literature. Vojnosanit Pregl 2017; 74(12): 1170–3.

Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int 2011; 107(9): 1474–8.

Stapleton A. Urinary tract infections in patients with diabetes. Am J Med 2002; 113 Suppl 1A: 80S–4S.

Lu YC, Chiang BJ, Pong YH, Chen CH, Pu YS, Hsueh PR, et al. “Emphysematous pyelonephritis: clinical characteristics and prognostic factors. Int J Urol 2014; 21(3): 277–82.

Schicho A, Stroszczynski C, Wiggermann P. Emphysematous cystitis: mortality, risk factors, and pathogens of a rare disease. Clin Pract 2017; 7(2): 930.

Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang CY, et al. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infect Dis 2014; 14: 418.

Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D. Retrospective analysis of clinical profile, prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol 2009; 41(4): 959–66.

Angulo JC, Dehaini A, Escribano J, Sanchez-Chapado M. Successful conservative management of emphysematous pyelonephritis, bilateral or in a solitary kidney. Scand J Urol Nephrol 1997; 31(2): 193–7.

Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, et al. Emphysematous pyelonephritis: time for a management plan with an evidence-based approach. Arab J Urol 2014; 12(2): 106–15.

Kalathia J, Chipde SS, Agrawal S, Agrawal R. Nephron-sparing surgery in case of emphysematous pyelonephritis. Urol Ann 2015; 7(4): 504−6.

Obostrani emfizematozni pijelonefritis i emfizematozni cistitis

Sažetak

Reference